13FPulse
BI

BIIB BIOGEN INC

2026Q2 · CUSIP 09062X103 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
1,015
Institutions that reported holding it to the SEC
Net increase in holders
+12
Last quarter 1,003 → now 1,015
How unusual is that
Above average
Stronger buying than 73% of US stocks
What the filings say, in one paragraph

1,015 funds held BIIB at the end of 2026Q2, up 12 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $9.9B(YoY +1.2%), the P/E is 23.3x, return on equity is 7.4%. BIIB has had 20 buying rushes in its history, and the price moved -3.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=624 2013Q4: holders=698 2014Q1: holders=743 2014Q2: holders=746 2014Q3: holders=783 2014Q4: holders=842 2015Q1: holders=919 2015Q2: holders=927 2015Q3: holders=880 2015Q4: holders=922 2016Q1: holders=913 2016Q2: holders=930 2016Q3: holders=970 2016Q4: holders=988 2017Q1: holders=987 2017Q2: holders=959 2017Q3: holders=972 2017Q4: holders=1078 2018Q1: holders=1066 2018Q2: holders=1058 2018Q3: holders=1112 2018Q4: holders=1106 2019Q1: holders=1055 2019Q2: holders=983 2019Q3: holders=970 2019Q4: holders=1072 2020Q1: holders=1073 2020Q2: holders=1035 2020Q3: holders=1028 2020Q4: holders=1044 2021Q1: holders=1072 2021Q2: holders=1088 2021Q3: holders=1030 2021Q4: holders=1004 2022Q1: holders=949 2022Q2: holders=918 2022Q3: holders=975 2022Q4: holders=1020 2023Q1: holders=994 2023Q2: holders=996 2023Q3: holders=951 2023Q4: holders=991 2024Q1: holders=942 2024Q2: holders=938 2024Q3: holders=913 2024Q4: holders=874 2025Q1: holders=875 2025Q2: holders=861 2025Q3: holders=902 2025Q4: holders=996 2026Q1: holders=1003 2026Q2: holders=1015 -106 -53 +0 +53 +106 5618651168 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 20 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q4 Top 5% -2.2%
2025Q3 Top 10% +16.6% +14.0%
2023Q4 Top 20% +5.2% -5.9%
2022Q4 Top 10% +12.5% -3.8%
2022Q3 Top 1% in the market -7.2% +2.8%
2021Q2 Top 20% -23.5% -37.2%
2021Q1 Top 20% +21.3% -7.2%
2019Q4 Top 5% -4.9% -13.1%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
321
Change in large funds
+34
Total value they hold
$33.1B
Funds buying for the first time
126
Funds that sold out entirely
114
Price change that quarter
+12.9%
Funds holding puts (bearish)
24
Funds holding calls (bullish)
29

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
23.3
EPS (TTM)
$9.30
EPS YoY
-8.1%
Revenue (TTM)
$9.9B
Revenue YoY
+1.2%
Net margin
13.8%
ROE
7.4%
Debt ratio
36.7%
FCF (TTM)
$2.4B
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2022-06-30: EPS 7.24 2022-09-30: EPS 7.84 2022-12-31: EPS 3.73 2023-03-31: EPS 2.67 2023-06-30: EPS 4.07 2023-09-30: EPS -0.47 2023-12-31: EPS 1.70 2024-03-31: EPS 2.70 2024-06-30: EPS 4.00 2024-09-30: EPS 2.66 2024-12-31: EPS 1.82 2025-03-31: EPS 1.64 2025-06-30: EPS 4.33 2025-09-30: EPS 3.17 2025-12-31: EPS -0.35 2026-03-31: EPS 2.15 0B 1.8B 3.7B $B -0.52 4.05 8.62 20162017201820192020202120222023202420252026 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 15 11 21 30 2023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-453M698M1.8B 20162017201820192020202120222023202420252026
Latest quarter $594M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-03-31 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.